Genetic counselling, patient education, and informed decision-making in the genomic era
- PMID: 29233487
- DOI: 10.1016/j.siny.2017.11.010
Genetic counselling, patient education, and informed decision-making in the genomic era
Abstract
Genomic technologies are now being applied to reproductive genetic screening. Circulating cell-free DNA testing in pregnancy for fetal chromosomal abnormalities is becoming more widely used as a screening test, and expanded carrier screening for autosomal and X-linked recessive conditions for more than a hundred conditions is available to couples for testing before and during pregnancy. These are most typically available as a commercial test. The purpose of reproductive genetic screening is to facilitate autonomous reproductive choices. Previous studies would suggest that many women do not make informed decisions about prenatal genetic screening, and the introduction of genomic technologies has generally added to the ethical debate. Appropriate pre-test genetic counselling is recommended, and healthcare providers should include information that is balanced, accurate and up-to-date, comprising written and/or e-learning tools, as well as providing psychosocial support so that couples consider the pros and cons of being tested and can make informed decisions.
Keywords: Cell-free DNA; Genetic counselling; Informed decision-making; Non-invasive prenatal testing; Prenatal testing; Reproductive genetic screening.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Screening for fetal chromosomal and subchromosomal disorders.Semin Fetal Neonatal Med. 2018 Apr;23(2):85-93. doi: 10.1016/j.siny.2017.10.006. Epub 2017 Nov 8. Semin Fetal Neonatal Med. 2018. PMID: 29128491 Free PMC article. Review.
-
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.J Obstet Gynaecol Can. 2016 Aug;38(8):742-762.e3. doi: 10.1016/j.jogc.2016.06.008. J Obstet Gynaecol Can. 2016. PMID: 27638987
-
Beyond screening for chromosomal abnormalities: Advances in non-invasive diagnosis of single gene disorders and fetal exome sequencing.Semin Fetal Neonatal Med. 2018 Apr;23(2):94-101. doi: 10.1016/j.siny.2017.12.002. Epub 2018 Jan 2. Semin Fetal Neonatal Med. 2018. PMID: 29305293 Review.
-
Prenatal genetic carrier testing using triple disease screening.JAMA. 1997 Oct 15;278(15):1268-72. JAMA. 1997. PMID: 9333269
-
Parental experiences after prenatal diagnosis of fetal abnormality.Semin Fetal Neonatal Med. 2018 Apr;23(2):150-154. doi: 10.1016/j.siny.2017.11.009. Epub 2017 Dec 16. Semin Fetal Neonatal Med. 2018. PMID: 29258838
Cited by
-
Disparities in integrating non-invasive prenatal testing into antenatal healthcare in Australia: a survey of healthcare professionals.BMC Pregnancy Childbirth. 2024 May 14;24(1):355. doi: 10.1186/s12884-024-06565-1. BMC Pregnancy Childbirth. 2024. PMID: 38745131 Free PMC article.
-
Evaluation of the digital genetic assistant in technology assisted genetic counseling for genetic carrier screening.NPJ Digit Med. 2025 Mar 29;8(1):183. doi: 10.1038/s41746-025-01573-7. NPJ Digit Med. 2025. PMID: 40158019 Free PMC article.
-
Evolution of virtual gene panels over time and implications for genomic data re-analysis.Genet Med Open. 2023 May 30;1(1):100820. doi: 10.1016/j.gimo.2023.100820. eCollection 2023. Genet Med Open. 2023. PMID: 39669234 Free PMC article.
-
Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives.Cells. 2024 Mar 13;13(6):504. doi: 10.3390/cells13060504. Cells. 2024. PMID: 38534348 Free PMC article. Review.
-
The implementation of large-scale genomic screening or diagnostic programmes: A rapid evidence review.Eur J Hum Genet. 2023 Mar;31(3):282-295. doi: 10.1038/s41431-022-01259-8. Epub 2022 Dec 14. Eur J Hum Genet. 2023. PMID: 36517584 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous